Moonshot AI Expands Into Singapore
Oct 21, 2026
Language Models
Moon Surgical's AI-Enhanced ScoPilot Gains FDA Clearance
Mar 19, 2025
Moon Surgical has received FDA clearance for its AI-powered ScoPilot feature on the Maestro System, utilizing NVIDIA Holoscan for enhanced surgical capabilities.
Moon Surgical has received FDA clearance for its ScoPilot feature on the Maestro System, announced in a press release. ScoPilot, powered by NVIDIA Holoscan, is the first AI application to operate intraoperatively on a commercial surgical robotic platform. This feature allows surgeons to maintain control of the laparoscope without disengaging from their instruments, enhancing surgical flow and focus.
The Maestro System, which was FDA-cleared in June 2024, has been used in over 1,100 surgeries across the United States and Europe. It leverages NVIDIA-accelerated computing and AI to generate extensive surgical datasets, driving the development of next-generation Physical AI capabilities. Moon Surgical's collaboration with NVIDIA aims to further advance the Maestro System's AI capabilities through the NVIDIA Isaac for Healthcare platform, as detailed in a press release.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly, Robotics Brief or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 22 Microsoft GPT-5 Diagnostic System Outperforms Doctors in Science Study Oct 22 BioStack Raises $9.5 Million for Medical AI Data Network Oct 22 Warp Sciences Raises $215 Million to Automate Drug Discovery Labs Oct 22 FDA Clears RIVANNA BoneEnhance Software for Accuro XV Oct 22 Tufts Medicine Uses Humata Health to Automate Prior AuthorizationMore from Robotics
Oct 22 Noetix Robotics Files Confidentially for Hong Kong IPO Oct 22 Warp Sciences Raises $215 Million to Automate Drug Discovery Labs Oct 22 Human Friendly Robotics Signs $3.55 Million Tyler Robot Contract With Foley Tile Oct 22 NVIDIA Expands Cosmos With World Model Training and Simulation Tools Oct 22 FORT Robotics Gets $20 Million in Investor CommitmentsFree newsletter
Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
The Hackett Group
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
The Saffron Solution Brings AI Workflow Tools to AAO 2026
Oct 08, 2026
Healthcare
AIRS Medical Gets FDA Clearance for MRI Body Composition Tool
Oct 06, 2026
Healthcare
Market Logic Launches DeepSights MCP for AI Assistants
Oct 07, 2026
Model Context Protocol
XRlabs Raises €7.48 Million for Surgical AI
Oct 20, 2026
Funding
DeepSight Technology Adds Scott Huennekens to Board
Oct 12, 2026
Healthcare
Free, six days a week
Daily AI Brief: the AI news that matters, in your inbox.